SAB Biotherapeutics (SABS) Stock Chart & Stock Price History → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free SABS Stock Alerts $2.94 +0.10 (+3.52%) (As of 06/7/2024 08:52 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends SAB Biotherapeutics Stock Price Performance5 Day Performance+14.54%1 Month Performance-26.41%3 Month Performance-45.08%6 Month Performance+250.22%Year-To-Date Performance+328.16%1 Year Performance+223.47% Receive SABS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SAB Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. SABS Stock Chart for Monday, June, 10, 2024 SABS Chart by TradingView SAB Biotherapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$2.84$2.98+4.93%$3.22$2.919,274 shs$27.51 million06/06/2024$2.73$2.84+4.03%$3.07$2.6461,147 shs$26.21 million06/05/2024$2.57$2.73+6.23%$2.73$2.489,032 shs$25.20 million06/04/2024$2.67$2.57-3.75%$2.69$2.511,565 shs$23.72 million06/03/2024$2.64$2.67+1.14%$2.67$2.4811,135 shs$24.64 million05/31/2024$2.64$2.64$2.64$2.474,222 shs$24.37 million Get the Latest News and Ratings for SABS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SAB Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$2.82$2.64-6.38%$2.82$2.6410,170 shs$24.37 million05/29/2024$2.73$2.82+3.30%$2.82$2.723,400 shs$26.03 million05/28/2024$2.72$2.73+0.37%$2.73$2.623,483 shs$25.20 million05/27/2024$2.72$2.72$2.80$2.5114,400 shs$25.11 million05/24/2024$2.58$2.75+6.59%$2.80$2.5113,976 shs$25.38 million05/23/2024$2.77$2.58-6.86%$2.93$2.3647,992 shs$23.81 million05/22/2024$2.91$2.77-4.81%$2.99$2.6756,892 shs$25.57 million05/21/2024$3.45$2.91-15.65%$3.33$2.50355,129 shs$26.86 million05/20/2024$3.63$3.45-4.96%$3.50$3.3828,650 shs$31.84 million05/17/2024$3.87$3.63-6.20%$3.79$3.5212,221 shs$33.51 million05/16/2024$3.93$3.87-1.53%$3.96$3.8415,976 shs$35.72 million05/15/2024$4.05$3.93-2.84%$4.07$3.931,803 shs$36.27 million05/14/2024$4.16$4.05-2.76%$4.18$3.7210,964 shs$37.34 million05/13/2024$4.01$4.16+3.74%$4.20$3.9512,185 shs$38.40 million05/10/2024$4.00$4.01+0.25%$4.21$4.004,830 shs$37.01 million05/09/2024$4.22$4.00-5.21%$4.14$4.004,024 shs$36.92 million05/08/2024$4.09$4.22+3.18%$4.35$4.108,954 shs$38.95 million05/07/2024$3.94$4.09+3.81%$4.50$4.0114,549 shs$37.75 million05/06/2024$4.03$3.94-2.23%$4.18$3.9413,187 shs$36.37 million05/03/2024$4.02$4.03+0.25%$4.10$4.002,533 shs$37.20 million05/02/2024$4.14$4.02-2.90%$4.30$4.0212,181 shs$37.11 million05/01/2024$4.29$4.14-3.50%$4.29$4.10330 shs$38.21 million04/30/2024$4.19$4.29+2.39%$4.30$4.12805 shs$39.60 million04/29/2024$4.25$4.19-1.41%$4.27$4.182,681 shs$38.67 million04/26/2024$4.01$4.20+4.74%$4.39$4.104,877 shs$38.77 million04/25/2024$4.40$4.01-8.86%$4.01$4.01666 shs$37.01 million04/24/2024$4.49$4.40-2.00%$4.40$4.40731 shs$40.61 million04/23/2024$4.41$4.49+1.81%$4.49$4.38858 shs$41.44 million04/22/2024$4.29$4.41+2.80%$4.65$4.291,741 shs$40.70 million04/19/2024$4.41$4.29-2.72%$4.31$4.29891 shs$39.60 million04/18/2024$4.60$4.41-4.13%$4.71$4.342,927 shs$40.70 million04/17/2024$4.72$4.60-2.54%$4.85$4.343,552 shs$42.46 million04/16/2024$4.36$4.72+8.26%$4.94$4.536,922 shs$43.57 million04/15/2024$4.68$4.36-6.74%$4.78$4.363,058 shs$40.24 millionYou won't believe what Citigroup just did to it's depositors (Ad)The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW04/12/2024$4.50$4.64+3.00%$4.68$4.603,497 shs$42.78 million04/11/2024$4.55$4.50-1.10%$4.50$4.50687 shs$41.54 million04/10/2024$4.46$4.55+2.02%$4.55$4.492,577 shs$42.00 million04/09/2024$4.46$4.46$4.49$4.461,609 shs$41.17 million04/08/2024$4.34$4.46+2.76%$4.46$4.251,014 shs$41.15 million04/05/2024$4.42$4.34-1.81%$4.62$4.254,071 shs$22.70 million04/04/2024$4.46$4.42-0.90%$4.65$4.269,005 shs$23.13 million04/03/2024$4.50$4.46-0.89%$4.86$4.464,287 shs$23.33 million04/02/2024$4.29$4.50+4.90%$4.72$4.478,491 shs$23.54 million04/01/2024$4.54$4.29-5.51%$4.51$4.265,424 shs$22.44 million03/29/2024$4.54$4.54$4.67$4.354,771 shs$23.75 million03/28/2024$4.22$4.54+7.58%$4.67$4.224,771 shs$23.74 million03/27/2024$4.17$4.22+1.20%$4.43$4.172,308 shs$22.07 million03/26/2024$4.25$4.17-1.88%$4.43$4.0020,444 shs$21.81 million03/25/2024$4.88$4.25-12.91%$4.95$4.1123,974 shs$22.23 million03/22/2024$4.69$4.88+4.05%$4.88$4.791,351 shs$25.52 million03/21/2024$4.79$4.69-2.09%$4.80$4.695,692 shs$24.53 million03/20/2024$4.80$4.79-0.21%$4.91$4.702,756 shs$25.05 million03/19/2024$5.40$4.80-11.11%$5.52$4.8031,103 shs$25.11 million03/18/2024$5.52$5.40-2.17%$5.89$5.4010,789 shs$28.24 million03/15/2024$6.00$5.52-8.00%$6.30$5.5298,407 shs$28.87 million03/14/2024$5.79$6.00+3.63%$6.09$5.7912,807 shs$31.39 million03/13/2024$5.86$5.79-1.19%$6.15$5.7929,930 shs$30.28 million03/12/2024$5.49$5.86+6.74%$5.88$5.1220,215 shs$30.65 million03/11/2024$5.36$5.49+2.43%$5.50$5.3616,499 shs$28.71 million03/08/2024$5.32$5.36+0.75%$5.36$5.0913,549 shs$28.03 million Related Companies: VSTM Stock Chart CRIS Stock Chart FBIO Stock Chart BOLT Stock Chart MTEM Stock Chart AMGN Stock Chart VRTX Stock Chart REGN Stock Chart GILD Stock Chart BIIB Stock Chart Receive SABS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for SAB Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SABS) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SAB Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SAB Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.